CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
Device comfort and performance hinge on one critical component: the right wearable adhesive. Learn how early wear studies can differentiate your device and boost market success in this webinar.
